Medtronic plc Net Income (Loss) Available to Common Stockholders, Basic
Medtronic plc (MDT) reported Net Income (Loss) Available to Common Stockholders, Basic of $1.27 billion for the 3-month period ending 2021-01-29, per its 10-Q filed 2021-03-05.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2021-03-05
- Medtronic plc net income (loss) available to common stockholders, basic for the quarter ending 2021-01-29 was $1.27B, a 33.68% decline year-over-year.
- Medtronic plc net income (loss) available to common stockholders, basic for the quarter ending 2020-10-30 was $489.00M, a 64.15% decline year-over-year.
- Medtronic plc net income (loss) available to common stockholders, basic for the quarter ending 2020-07-31 was $487.00M, a 43.63% decline year-over-year.
- Medtronic plc net income (loss) available to common stockholders, basic for the quarter ending 2020-01-24 was $1.92B, a 50.91% increase year-over-year.
- Medtronic plc net income (loss) available to common stockholders, basic for fiscal 2016 was $3.54B, a 32.26% increase from fiscal 2015.
- Medtronic plc net income (loss) available to common stockholders, basic for fiscal 2015 was $2.67B, a 12.72% decline from fiscal 2014.
- Medtronic plc net income (loss) available to common stockholders, basic for fiscal 2014 was $3.06B, a 11.60% decline from fiscal 2013.
- Medtronic plc net income (loss) available to common stockholders, basic for fiscal 2013 was $3.47B.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2021-01-29 | $1.27B 10-Q · filed 2021-03-05 | $1.76B derived: sum of 2 quarters · filed 2021-03-05 | $2.25B 10-Q · filed 2021-03-05 | |
| 2020-10-30 | $489.00M 10-Q · filed 2020-12-03 | $976.00M 10-Q · filed 2020-12-03 | ||
| 2020-07-31 | $487.00M 10-Q · filed 2020-09-03 | |||
| 2020-01-24 | $1.92B 10-Q · filed 2021-03-05 | $3.28B derived: sum of 2 quarters · filed 2021-03-05 | $4.14B 10-Q · filed 2021-03-05 | |
| 2019-10-25 | $1.36B 10-Q · filed 2020-12-03 | $2.23B 10-Q · filed 2020-12-03 | ||
| 2019-07-26 | $864.00M 10-Q · filed 2020-09-03 | |||
| 2019-01-25 | $1.27B 10-Q · filed 2020-02-28 | $2.38B derived: sum of 2 quarters · filed 2020-02-28 | $3.46B 10-Q · filed 2020-02-28 | |
| 2018-10-26 | $1.11B 10-Q · filed 2019-12-03 | $2.19B 10-Q · filed 2019-12-03 | ||
| 2018-07-27 | $1.07B 10-Q · filed 2019-08-30 | |||
| 2018-01-26 | -$1.39B 10-Q · filed 2019-03-01 | $628.00M derived: sum of 2 quarters · filed 2019-03-01 | $1.64B 10-Q · filed 2019-03-01 | |
| 2017-10-27 | $2.02B 10-Q · filed 2018-11-29 | $3.03B 10-Q · filed 2018-11-29 | ||
| 2017-07-28 | $1.02B 10-Q · filed 2018-08-31 | |||
| 2017-01-27 | $821.00M 10-Q · filed 2018-03-02 | $1.94B derived: sum of 2 quarters · filed 2018-03-02 | $2.87B 10-Q · filed 2018-03-02 | $3.97B derived: sum of 4 quarters · filed 2018-03-02 |
| 2016-10-28 | $1.11B 10-Q · filed 2017-12-04 | $2.04B 10-Q · filed 2017-12-04 | $3.15B derived: sum of 3 quarters · filed 2017-12-04 | $4.24B derived: sum of 4 quarters · filed 2017-12-04 |
| 2016-07-29 | $929.00M 10-Q · filed 2017-09-01 | $2.03B derived: sum of 2 quarters · filed 2017-09-01 | $3.13B derived: sum of 3 quarters · filed 2017-09-01 | $3.65B derived: sum of 4 quarters · filed 2017-09-01 |
| 2016-04-29 | $1.10B derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-28 | $2.20B derived: sum of 2 quarters · filed 2017-03-03 | $2.72B derived: sum of 3 quarters · filed 2017-03-03 | $3.54B 10-K · filed 2016-06-28 |
| 2016-01-29 | $1.09B 10-Q · filed 2017-03-03 | $1.61B derived: sum of 2 quarters · filed 2017-03-03 | $2.44B 10-Q · filed 2017-03-03 | $2.43B derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-10-30 | $520.00M 10-Q · filed 2016-12-05 | $1.34B 10-Q · filed 2016-12-05 | $1.34B derived: sum of 3 quarters · filed 2016-12-05 | $2.32B derived: sum of 4 quarters · filed 2016-12-05 |
| 2015-07-31 | $820.00M 10-Q · filed 2016-09-07 | $819.00M derived: sum of 2 quarters · filed 2016-09-07 | $1.80B derived: sum of 3 quarters · filed 2016-09-07 | $2.62B derived: sum of 4 quarters · filed 2016-09-07 |
| 2015-04-24 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-28 | $976.00M derived: sum of 2 quarters · filed 2016-06-28 | $1.80B derived: sum of 3 quarters · filed 2016-06-28 | $2.67B 10-K · filed 2016-06-28 |
| 2015-01-23 | $977.00M 10-Q · filed 2016-03-09 | $1.80B derived: sum of 2 quarters · filed 2016-03-09 | $2.68B 10-Q · filed 2016-03-09 | |
| 2014-10-24 | $828.00M 10-Q · filed 2015-12-09 | $1.70B 10-Q · filed 2015-12-09 | ||
| 2014-07-25 | $871.00M 10-Q · filed 2015-09-09 | |||
| 2014-04-25 | $3.06B 10-K · filed 2016-06-28 | |||
| 2013-04-26 | $3.47B 10-K · filed 2015-06-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |